|
|
Environ Health Perspect. 2002 July; 110(7): 721–728. | PMCID: PMC1240919 |
Research Article Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Philip J Landrigan, Clyde B Schechter, Jeffrey M Lipton, Marianne C Fahs, and Joel Schwartz The Center for Children's Health and the Environment and The Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. phil.landrigan@mssm.edu In this study, we aimed to estimate the contribution of environmental pollutants to the incidence, prevalence, mortality, and costs of pediatric disease in American children. We examined four categories of illness: lead poisoning, asthma, cancer, and neurobehavioral disorders. To estimate the proportion of each attributable to toxins in the environment, we used an environmentally attributable fraction (EAF) model. EAFs for lead poisoning, asthma, and cancer were developed by panels of experts through a Delphi process, whereas that for neurobehavioral disorders was based on data from the National Academy of Sciences. We define environmental pollutants as toxic chemicals of human origin in air, food, water, and communities. To develop estimates of costs, we relied on data from the U.S. Environmental Protection Agency, Centers for Disease Control and Prevention, National Center for Health Statistics, the Bureau of Labor Statistics, the Health Care Financing Agency, and the Practice Management Information Corporation. EAFs were judged to be 100% for lead poisoning, 30% for asthma (range, 10-35%), 5% for cancer (range, 2-10%), and 10% for neurobehavioral disorders (range, 5-20%). Total annual costs are estimated to be $54.9 billion (range $48.8-64.8 billion): $43.4 billion for lead poisoning, $2.0 billion for asthma, $0.3 billion for childhood cancer, and $9.2 billion for neurobehavioral disorders. This sum amounts to 2.8 percent of total U.S. health care costs. This estimate is likely low because it considers only four categories of illness, incorporates conservative assumptions, ignores costs of pain and suffering, and does not include late complications for which etiologic associations are poorly quantified. The costs of pediatric environmental disease are high, in contrast with the limited resources directed to research, tracking, and prevention. The Full Text of this article is available as a PDF (569K). These references are in PubMed. This may not be the complete list of references from this article. - DiLiberti JH, Jackson CR. Long-term trends in childhood infectious disease mortality rates. Am J Public Health. 1999 Dec;89(12):1883–1885. [PubMed]
- Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF., Jr Recent cancer trends in the United States. J Natl Cancer Inst. 1995 Feb 1;87(3):175–182. [PubMed]
- Zahm SH, Devesa SS. Childhood cancer: overview of incidence trends and environmental carcinogens. Environ Health Perspect. 1995 Sep;103 Suppl 6:177–184. [PubMed]
- Kiely M. The prevalence of mental retardation. Epidemiol Rev. 1987;9:194–218. [PubMed]
- Paulozzi LJ, Erickson JD, Jackson RJ. Hypospadias trends in two US surveillance systems. Pediatrics. 1997 Nov;100(5):831–834. [PubMed]
- Hussain Naveed, Chaghtai Azhar, Herndon C D Anthony, Herson Victor C, Rosenkrantz Ted S, McKenna Patrick H. Hypospadias and early gestation growth restriction in infants. Pediatrics. 2002 Mar;109(3):473–478. [PubMed]
- Goldman LR, Koduru S. Chemicals in the environment and developmental toxicity to children: a public health and policy perspective. Environ Health Perspect. 2000 Jun;108 Suppl 3:443–448. [PubMed]
- Pirkle JL, Kaufmann RB, Brody DJ, Hickman T, Gunter EW, Paschal DC. Exposure of the U.S. population to lead, 1991-1994. Environ Health Perspect. 1998 Nov;106(11):745–750. [PubMed]
- Schwartz J. Societal benefits of reducing lead exposure. Environ Res. 1994 Jul;66(1):105–124. [PubMed]
- Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992 Mar 26;326(13):862–866. [PubMed]
- Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):787–793. [PubMed]
- Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000 Sep;106(3):493–499. [PubMed]
- Leigh JP, Markowitz SB, Fahs M, Shin C, Landrigan PJ. Occupational injury and illness in the United States. Estimates of costs, morbidity, and mortality. Arch Intern Med. 1997 Jul 28;157(14):1557–1568. [PubMed]
- Fahs MC, Markowitz SB, Fischer E, Shapiro J, Landrigan PJ. Health costs of occupational disease in New York State. Am J Ind Med. 1989;16(4):437–449. [PubMed]
- Fahs MC, Mandelblatt J, Schechter C, Muller C. Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med. 1992 Sep 15;117(6):520–527. [PubMed]
- de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, van der Maas PJ. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer. 1991 Oct 21;49(4):531–537. [PubMed]
- Landrigan PJ, Carlson JE. Environmental policy and children's health. Future Child. 1995 Summer–Fall;5(2):34–52. [PubMed]
- Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics. 1992 Nov;90(5):657–662. [PubMed]
- Arrow KJ, Cropper ML, Eads GC, Hahn RW, Lave LB, Noll RG, Portney PR, Russell M, Schmalensee R, Smith VK, Stavins RN. Is there a role for benefit-cost analysis in environmental, health, and safety regulation? Science. 1996 Apr 12;272(5259):221–222. [PubMed]
- Smith KR, Corvalán CF, Kjellström T. How much global ill health is attributable to environmental factors? Epidemiology. 1999 Sep;10(5):573–584. [PubMed]
- Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ, Jr, Rhoads GG. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med. 2001 May 10;344(19):1421–1426. [PubMed]
- Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984 Sep;74(9):979–983. [PubMed]
- Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care. 1986;2(1):53–63. [PubMed]
- Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, Barrett P. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med. 1979 Mar 29;300(13):689–695. [PubMed]
- Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990 Jan 11;322(2):83–88. [PubMed]
- Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent behavior. JAMA. 1996 Feb 7;275(5):363–369. [PubMed]
- Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect. 1991 Feb;91:71–75. [PubMed]
- Salkever DS. Updated estimates of earnings benefits from reduced exposure of children to environmental lead. Environ Res. 1995 Jul;70(1):1–6. [PubMed]
- Ostro B, Chestnut L. Assessing the health benefits of reducing particulate matter air pollution in the United States. Environ Res. 1998 Feb;76(2):94–106. [PubMed]
- Woodruff TJ, Grillo J, Schoendorf KC. The relationship between selected causes of postneonatal infant mortality and particulate air pollution in the United States. Environ Health Perspect. 1997 Jun;105(6):608–612. [PubMed]
- Stempel DA, Hedblom EC, Durcanin-Robbins JF, Sturm LL. Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures. Arch Fam Med. 1996 Jan;5(1):36–40. [PubMed]
- Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev. 1985 Fall;7(1):61–80. [PubMed]
- Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group. Epidemiology. 2000 Nov;11(6):624–634. [PubMed]
- Zahm SH, Ward MH. Pesticides and childhood cancer. Environ Health Perspect. 1998 Jun;106 Suppl 3:893–908. [PubMed]
- Colt JS, Blair A. Parental occupational exposures and risk of childhood cancer. Environ Health Perspect. 1998 Jun;106 Suppl 3:909–925. [PubMed]
- Daniels JL, Olshan AF, Savitz DA. Pesticides and childhood cancers. Environ Health Perspect. 1997 Oct;105(10):1068–1077. [PubMed]
- Robison LL, Buckley JD, Bunin G. Assessment of environmental and genetic factors in the etiology of childhood cancers: the Childrens Cancer Group epidemiology program. Environ Health Perspect. 1995 Sep;103 Suppl 6:111–116. [PubMed]
- Meadows AT. Risk factors for second malignant neoplasms: report from the Late Effects Study Group. Bull Cancer. 1988;75(1):125–130. [PubMed]
- Miké V, Meadows AT, D'Angio GJ. Incidence of second malignant neoplasms in children: results of an international study. Lancet. 1982 Dec 11;2(8311):1326–1331. [PubMed]
- Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995 Apr 15;75(8):2186–2195. [PubMed]
- de Vathaire F, Schweisguth O, Rodary C, François P, Sarrazin D, Oberlin O, Hill C, Raquin MA, Dutreix A, Flamant R. Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer. 1989 Mar;59(3):448–452. [PubMed]
- Silber JH, Radcliffe J, Peckham V, Perilongo G, Kishnani P, Fridman M, Goldwein JW, Meadows AT. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol. 1992 Sep;10(9):1390–1396. [PubMed]
- Lanphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep. 2000 Nov–Dec;115(6):521–529. [PubMed]
- Miller TR, Galbraith M. Estimating the costs of occupational injury in the United States. Accid Anal Prev. 1995 Dec;27(6):741–747. [PubMed]
- Neumark D, Johnson RW, Bresnitz EA, Frumkin H, Hodgson M, Needleman C. Costs of occupational injury and illness in Pennsylvania. J Occup Med. 1991 Sep;33(9):971–976. [PubMed]
- Park RE, Fink A, Brook RH, Chassin MR, Kahn KL, Merrick NJ, Kosecoff J, Solomon DH. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health. 1986 Jul;76(7):766–772. [PubMed]
- Koplan JP, Farer LS. Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique. JAMA. 1980 Dec 19;244(24):2736–2740. [PubMed]
- Berkowitz GS, Wolff MS, Matte T, Susser E, Landrigan PJ. The rationale for a national prospective cohort study of environmental exposure and childhood development. Environ Res. 2001 Feb;85(2):59–68. [PubMed]
|